On 2024-6-12, the latest report 【Global Heparin Market 2024 by Manufacturers, Regions, Types and Applications, Forecast to 2030】from Global Info Research provides a detailed and comprehensive analysis of the global Heparin market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2024.
According to our (Global Info Research) latest study, the global Heparin market size was valued at USD 2404.6 million in 2023 and is forecast to a readjusted size of USD 3877.2 million by 2030 with a CAGR of 7.1% during review period.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
In this report, we mainly study the Heparin API.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
Heparin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type： Heparin Sodium、Heparin Calcium
Market segment by Application：UFH、LMWH
Major players covered：Shenzhen Hepalink Pharmaceutical、Yantai Dongcheng Pharmaceutical、Pfizer、Bioibérica、Changzhou Qianhong Biopharma、Nanjing King-friend Biochemical Pharmaceutical、Hebei Changshan Biochemical Pharmaceutical、Qingdao Jiulong Biopharmaceutical、Opocrin、Dongying Tiandong Pharmaceutical、Aspen Oss、Yino Pharma、Nanjing Xinbai Pharmaceutical、Hubei Enoray Biopharmaceutical、Cisen Pharmaceutical
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Heparin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Heparin, with price, sales quantity, revenue, and global market share of Heparin from 2019 to 2024.
Chapter 3, the Heparin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heparin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment Heparin the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the Heparin sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Heparin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Heparin.
Chapter 14 and 15, to describe Heparin sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Heparin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
According to our (Global Info Research) latest study, the global Heparin market size was valued at USD 2404.6 million in 2023 and is forecast to a readjusted size of USD 3877.2 million by 2030 with a CAGR of 7.1% during review period.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
In this report, we mainly study the Heparin API.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
Heparin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type： Heparin Sodium、Heparin Calcium
Market segment by Application：UFH、LMWH
Major players covered：Shenzhen Hepalink Pharmaceutical、Yantai Dongcheng Pharmaceutical、Pfizer、Bioibérica、Changzhou Qianhong Biopharma、Nanjing King-friend Biochemical Pharmaceutical、Hebei Changshan Biochemical Pharmaceutical、Qingdao Jiulong Biopharmaceutical、Opocrin、Dongying Tiandong Pharmaceutical、Aspen Oss、Yino Pharma、Nanjing Xinbai Pharmaceutical、Hubei Enoray Biopharmaceutical、Cisen Pharmaceutical
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Heparin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Heparin, with price, sales quantity, revenue, and global market share of Heparin from 2019 to 2024.
Chapter 3, the Heparin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heparin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment Heparin the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the Heparin sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Heparin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Heparin.
Chapter 14 and 15, to describe Heparin sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Heparin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
※コメント投稿者のブログIDはブログ作成者のみに通知されます